Healthcare It’s no longer a luxury to treat rare diseases — we must act accordingly Healthcare / 3 years ago by Marshall Summar, opinion contributor 12/02/21 12:01 PM ET
Healthcare Bipartisan measure can expedite development of therapies for rare diseases Healthcare / 3 years ago by Rep. Gus Bilirakis (R-Fla.), opinion contributor 04/15/21 8:30 AM ET
Healthcare COVID’s all-hands-on-deck approach should be standard for rare diseases Healthcare / 4 years ago by Christopher P. Austin, opinion contributor 03/18/21 12:31 PM ET
Healthcare Orphan drugs are not driving health care spending so let’s invest in them Healthcare / 7 years ago by Peter L. Saltonstall, opinion contributor 11/01/17 12:40 PM ET
Politics The Search for Cures Politics / 18 years ago by Dr. Alan Goldhammer, Deputy Director for Regulatory Affairs, Pharmaceutical Research Manufacturers of America 03/01/07 9:32 AM ET
